US Stock MarketDetailed Quotes
MEIP MEI Pharma
- 2.7000
- 0.00000.00%
Close Dec 13 16:00 ET
- 2.7000
- 0.00000.00%
Post 20:01 ET
17.99MMarket Cap-0.39P/E (TTM)
2.7000High2.6200Low14.11KVolume2.6500Open2.7000Pre Close37.48KTurnover0.29%Turnover Ratio1.01P/E (Static)6.66MShares6.520052wk High0.72P/B13.30MFloat Cap2.610052wk Low--Dividend TTM4.93MShs Float12210.9816Historical High--Div YieldTTM2.96%Amplitude2.6100Historical Low2.6560Avg Price1Lot Size
MEI Pharma Key Stats
Quarterly+Annual
YOY
| (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 38.08%-11.45M | 3.83%-50.47M | -59.25%-18M | 75.86%-2.93M | 22.53%-11.06M | -25.09%-18.49M | -7.67%-52.48M | 27.10%-11.3M | 28.46%-12.13M | -66.59%-14.27M |
| Net income from continuing operations | -114.20%-8.01M | 155.84%17.78M | -83.53%-18.41M | 40.88%-9.13M | -207.90%-11.06M | 439.11%56.37M | 41.53%-31.84M | 37.56%-10.03M | -76.94%-15.44M | 184.35%10.25M |
| Operating gains losses | --9K | 102.90%32K | ---- | ---- | ---- | ---- | 94.68%-1.1M | --0 | 103.91%500K | 91.10%-486K |
| Depreciation and amortization | 322.99%368K | -0.78%383K | 27.55%125K | -11.34%86K | -7.61%85K | -12.12%87K | 18.40%386K | 15.29%98K | 8.99%97K | 22.67%92K |
| Other non cash items | -42.47%214K | 70.26%2.43M | 254.37%1.3M | 7.22%386K | 6.78%378K | 6.59%372K | 57.21%1.43M | 34.07%366K | 92.51%360K | --354K |
| Change In working capital | 94.85%-3.9M | -237.82%-84.28M | -506.24%-12.34M | 253.04%5.06M | 94.84%-1.31M | -8,050.32%-75.69M | -247.83%-24.95M | -294.57%-2.04M | 0.21%1.43M | -507.93%-25.3M |
| -Change in receivables | --0 | -99.15%85K | --0 | --0 | --0 | -96.28%85K | 504.51%9.96M | 381.29%4.5M | -34.08%1.12M | -74.23%2.05M |
| -Change in prepaid assets | 198.87%1.58M | 255.27%4.53M | 113.53%390K | 1,466.56%4.09M | 39.95%-472K | -49.43%530K | -13,804.76%-2.92M | -234.22%-2.88M | 74.11%-299K | 27.49%-786K |
| -Change in payables and accrued expense | 50.57%-5.48M | -7,187.41%-10.42M | 91.16%-182K | -40.49%1.33M | -161.49%-479K | -904.80%-11.09M | -103.59%-143K | -615.79%-2.06M | -3.36%2.24M | -46.28%779K |
| -Change in other current liabilities | --0 | -979.46%-13.61M | -3,773.77%-12.55M | -13.21%-360K | -13.46%-354K | -13.03%-347K | -49.23%-1.26M | -62.00%-324K | -68.25%-318K | 31.13%-312K |
| -Change in other working capital | ---- | -112.09%-64.86M | --0 | --0 | --0 | -6,579.92%-64.86M | -288.52%-30.58M | -0.08%-1.27M | -5.20%-1.31M | -1,508.03%-27.03M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 38.08%-11.45M | 3.83%-50.47M | -59.25%-18M | 75.86%-2.93M | 22.53%-11.06M | -25.09%-18.49M | -7.67%-52.48M | 27.10%-11.3M | 28.46%-12.13M | -66.59%-14.27M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 196.49%14.7M | -8.47%49.14M | 0.76%19.54M | -98.78%122K | 132.74%24.52M | -63.91%4.96M | 679.02%53.69M | -3.56%19.4M | -33.85%10.03M | 124.29%10.53M |
| Net PPE purchase and sale | --10K | 80.00%-7K | --0 | --0 | -109.21%-7K | --0 | 92.69%-35K | 86.60%-41K | 93.86%-7K | 249.02%76K |
| Net investment purchase and sale | 196.29%14.69M | -8.52%49.15M | 0.55%19.54M | -98.78%122K | 134.50%24.52M | -64.07%4.96M | 628.87%53.73M | -4.80%19.44M | -34.30%10.03M | 124.14%10.46M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 196.49%14.7M | -8.47%49.14M | 0.76%19.54M | -98.78%122K | 132.74%24.52M | -63.91%4.96M | 679.02%53.69M | -3.56%19.4M | -33.85%10.03M | 124.29%10.53M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -29,570.00%-11.87M | -208K | 0 | -100.08%-40K | 0 | 0 | 0 | |||
| Cash dividends paid | ---- | ---11.66M | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
| Net other financing activities | ---- | -420.00%-208K | ---- | ---- | ---- | ---- | 98.96%-40K | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | -29,570.00%-11.87M | ---208K | --0 | ---- | ---- | -100.08%-40K | --0 | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -78.08%3.71M | 7.41%16.91M | -73.13%2.37M | -52.61%5.17M | -76.99%3.37M | 7.41%16.91M | 84.24%15.74M | -20.70%8.81M | -13.02%10.92M | -6.20%14.65M |
| Current changes in cash | 123.99%3.25M | -1,232.16%-13.2M | -83.48%1.34M | -33.30%-2.81M | 148.23%1.8M | -1,145.08%-13.53M | -83.80%1.17M | 74.89%8.09M | -46.28%-2.11M | -21.69%-3.74M |
| End cash Position | 106.17%6.95M | -78.08%3.71M | -78.08%3.71M | -73.13%2.37M | -52.61%5.17M | -76.99%3.37M | 7.41%16.91M | 7.41%16.91M | -20.70%8.81M | -13.02%10.92M |
| Free cash flow | 38.08%-11.45M | 3.88%-50.48M | -58.76%-18M | 75.86%-2.93M | 22.14%-11.06M | -24.56%-18.49M | -6.69%-52.52M | 28.29%-11.34M | 28.94%-12.13M | -64.87%-14.21M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data